The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience
Kai Ninomiya(Ollscoil na Gaillimhe – University of Galway), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Helge Möllmann(St.-Johannes-Hospital Dortmund), Rohit M. Oemrawsingh(Albert Schweitzer Ziekenhuis), Nozomi Kotoku(St. Marianna University School of Medicine), Bruno Farah, William Wijns(Ollscoil na Gaillimhe – University of Galway), Emelyne Sevestre(Ollscoil na Gaillimhe – University of Galway), Stephan Achenbach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Shinichiro Masuda(Iwate Medical University), Faisal Sharif(Ollscoil na Gaillimhe – University of Galway), Nicolas Méneveau(Université de Franche-Comté), Azfar Zaman(Royal Stoke University Hospital), Abdelhakim Allali(Segeberger Kliniken), Scot Garg(East Lancashire Hospitals NHS Trust), Sean Gallagher(Auburn University), Patrick W. Serruys(Erasmus MC), Peter O’Kane(Royal Bournemouth Hospital), Maciej Lesiak, Shigetaka Kageyama(Ollscoil na Gaillimhe – University of Galway), Marc Silvestri, Julien Lemoine(Clinique Pasteur), Abhishek Kumar(Manipal Academy of Higher Education), Joanna J. Wykrzykowska(University Medical Center Groningen), Hironori Hara(Tokyo University of Information Sciences), Michael Magro(Elisabeth-TweeSteden Ziekenhuis)
Cited by 5
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k